Gregory Steiner, MD
Surgery · Baltimore, MDNPI 1841557188
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $9,035 of the $14,376 with a category attached, or 62.8%. 30 manufacturers reported payments, led by Medtronic at 47.3% of the total. Reporting peaked in 2024 at $6,999 and has fallen 54.5% since, to $3,183 in 2025. Among surgery clinicians in MD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 132 payments — averaging $108.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$7K
- Penumbra, Inc.$3K
- Silk Road Medical, Inc.$1K
- W. L. Gore & Associates, Inc.$829
- Angiodynamics, Inc.$398
- Inari Medical, Inc.$295
- plus $2K from 24 others
What the payments were for
- Travel & lodging$9,03563%
- Food & beverage$5,34237%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 33 | $6,798 |
| Penumbra, Inc. | 8 | $3,075 |
| Silk Road Medical, Inc. | 17 | $1,280 |
| W. L. Gore & Associates, Inc. | 9 | $829 |
| Angiodynamics, Inc. | 9 | $398 |
| Inari Medical, Inc. | 2 | $295 |
| Bolton Medical Inc | 3 | $203 |
| Cardinal Health 200 LLC | 3 | $186 |
| Cook Medical LLC | 6 | $169 |
| Lemaitre Vascular, Inc. | 5 | $159 |
| Abbott | 2 | $153 |
| Smith+Nephew | 5 | $144 |
| Bard Peripheral Vascular, Inc. | 4 | $89 |
| Cordis US CORP. | 1 | $86 |
| Johnson & Johnson | 4 | $80 |
| Getinge USA Sales, LLC | 3 | $57 |
| Misonix Inc | 1 | $51 |
| Pfizer | 3 | $49 |
| Surmodics, Inc. | 2 | $47 |
| Boston Scientific | 2 | $38 |
| Viz.ai, Inc. | 1 | $30 |
| Cardiovascular Systems Inc. | 1 | $24 |
| Cardiva Medical, Inc. | 1 | $21 |
| Baxter Healthcare | 1 | $20 |
| Terumo Medical Corporation | 1 | $20 |
| Polynovo North America LLC | 1 | $20 |
| Tactile Systems Technology Inc | 1 | $15 |
| EKOS Corporation | 1 | $14 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
| Integra Lifesciences Corporation | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENDURANT IIS$5,896
- Indigo System$2,848
- ENROUTE Transcarotid Neuroprotection System$1,069
- ENROUTE Transcarotid Stent System$541
- ENHANCE Transcarotid Peripheral Access Kit$541
- ENROUTE 0.014 Guidewire$541
- ENROUTE Transcarotid Stent$353
- GORE TAG Thoracic Branch Endoprosthesis$342
- FlowTriever$295
- ClotTriever$295
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$175
- Penumbra System$174
- Auryon Laser System 100-120 Vac$170
- GORE EXCLUDER AAA Endoprosthesis$146
- Grafts$145
- Valiant Captivia$139
- JETI$135
- C3 Delivery System$121
- Zilver PTX$105
How this compares
$14,376 in reported general payments places this provider in the 90th percentile of 493 surgery providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 94 | $72,636 |
| XareltoRivaroxaban | 13 | $12,517 |
| BrilintaTicagrelor | 11 | $4,881 |
| Cilostazol | 56 | $919 |
| ClopidogrelClopidogrel Bisulfate | 96 | $811 |
| Atorvastatin Calcium | 29 | $136 |
| Warfarin Sodium | 12 | $127 |
| Tramadol Hcl | 15 | $72 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $49 | $72,63694 claims |
| Johnson & JohnsonXarelto | $80 | $12,51713 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 493 surgery providers in Maryland.
Other surgery in Baltimore
- Dorry SegevBaltimore$1.2M
- Thomas SwopeBaltimore$775K
- Alisa CokerBaltimore$702K
- John LedonneBaltimore$329K
- Martin MakaryBaltimore$135K
- Murtaza DawoodBaltimore$82K
- Christopher YouBaltimore$79K
- Daniel LubelskiBaltimore$67K
- Stephen YangBaltimore$45K
- Amelia PasleyBaltimore$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.